Browsing: Loss

By Virginia Furness LONDON (Reuters) – Financial regulators and supervisors in some G20 countries are overlooking the risks posed by…

By Simon Jessop and Jake Spring LONDON/SAO PAULO (Reuters) – More than 100 companies, including Unilever (LON:), L’Occitane and Iberdrola…

BEIJING (Reuters) – Natural disasters in China resulted in 93.16 billion yuan ($12.83 billion) worth of direct economic loss in…

Pfizer on Thursday said it will move forward with a once-daily version of its weight loss pill, danuglipron, after it…

By Chad Terhune (Reuters) -Only one in four U.S. patients prescribed Novo Nordisk’s Wegovy or Ozempic for weight loss were…

LONDON (Reuters) – Shares in Novo Nordisk (NYSE:), maker of the wildly popular obesity drug Wegovy, were down 1.9% on…

By Matthias Williams and Kate Abnett LONDON/BRUSSELS (Reuters) – Many of France’s allies breathed a sigh of relief that the…

Tesla’s stock price rose enough on Friday to wipe out its loss for the year and bring its gain for…

As the use of popular weight loss and diabetes drugs like Wegovy and Ozempic skyrockets, consumer brands are scrambling to adapt.…

Novo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye…